NASDAQ · ARCIUFinancialsBlank Checks

Archimedes Tech SPAC Partners III Co. Units (ARCIU)

$10.25−0.53%
Close Sep 24, 2026 · split-adjusted
Sep 24, 2026$10.25▲ 1.14% in range
Jan 23, 2026Low $9.99 · High $10.43Sep 24, 2026
What changed · written from our data
As of Sep 28, 2026

Archimedes Tech SPAC Partners III Co. Units closed at $10.25 on Sep 24, down 0.53%, within 2.6% of its lowest close since Jan 23. Volume of 5.3K shares was 0.62× its 20-day average (below normal).

Short interest was 441 shares at the Sep 15 settlement, down 58.7% from the prior report (1.0 days to cover).

Market cap—
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yieldNone
Range since Jan 239.99 – 10.43−1.8% from high
Volume5.3K0.62× 20-day avg
Volatility · 60d7.4%Annualised
Short % of float—1.0 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W —1M —3M +0.5%6M —YTD —1Y —3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Blank Checks

Percentile among 164 companies (100 = best)

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Industry medians: 6-month return +2.1%, revenue growth −2.0%, net margin −34.2%, P/E 43.1×.

Short interest

Details →
Shares short441−58.7% vs prior
Days to cover1.0Settled Sep 15
% of float—
Short vol. 10d3.3%of daily volume

News about Archimedes Tech SPAC Partners III Co. Units

All news →

No recent articles focused on Archimedes Tech SPAC Partners III Co. Units.

Quick answers

What does Archimedes Tech SPAC Partners III Co. Units do?
Archimedes Tech SPAC Partners III Co is a blank check company.
What sector is ARCIU in?
Financials, in the Blank Checks industry.

About Archimedes Tech SPAC Partners III Co. Units

Archimedes Tech SPAC Partners III Co is a blank check company.

HQ: Claymont, DEListed Jan 23, 2026

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology